Coherus BioSciences CHRS
$ 1.47
-0.68%
Quarterly report 2024-Q3
added 11-06-2024
Coherus BioSciences Cash Flow 2011-2024 | CHRS
Annual Cash Flow Coherus BioSciences
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-175 M | -241 M | -37.4 M | 154 M | 28.4 M | -159 M | -200 M | -253 M | - | - | - | - | - |
Depreciation & Amortization |
3.2 M | 3.6 M | 3.5 M | 2.89 M | 3.26 M | 3.24 M | 3.4 M | 3 M | 1.87 M | 674 K | 404 K | 221 K | - |
Accounts Payables |
35.2 M | 11.5 M | 16.2 M | 15.2 M | 26 M | 15.3 M | 15.5 M | 19.7 M | 25.9 M | 8.78 M | - | - | - |
Accounts Receivables |
261 M | 110 M | 123 M | 157 M | 142 M | - | - | 1.86 M | 1.56 M | 2.42 M | - | - | - |
Total Inventories |
62.6 M | 38.8 M | 37.6 M | 44.2 M | 9.81 M | 1.66 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Coherus BioSciences
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -46.8 M | - | - | - | -68.7 M | - | -141 M | - | -54 M | - | 14.9 M | - | 1.37 M | - | 121 M | 73.7 M | 13.5 M | - | 10.6 M | -44.3 M | -57 M | - | -112 M | -69.1 M | -33.6 M | - | -170 M | -129 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
400 K | 500 K | 600 K | - | 800 K | 800 K | 900 K | - | 900 K | 900 K | 767 K | - | 900 K | 900 K | 849 K | - | 700 K | 700 K | 607 K | - | 800 K | 700 K | 691 K | - | 800 K | 902 K | 922 K | - | 800 K | 838 K | 865 K | - | 800 K | 729 K | 717 K | - | 636 K | 400 K | 232 K | - | 192 K | 131 K | 116 K | - | 101 K | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
21.9 M | 76.8 M | 38.3 M | 35.2 M | 37.1 M | 29.3 M | 23.2 M | 11.5 M | 9.92 M | - | 21.1 M | 16.2 M | 45.7 M | 14.6 M | 15.5 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 26 M | 26 M | 26 M | 26 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | 8.78 M | 8.78 M | 8.78 M | 8.78 M | 3.3 M | 3.3 M | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
168 M | 175 M | 252 M | 261 M | 217 M | 141 M | 101 M | 110 M | 91.2 M | - | 117 M | 123 M | 136 M | 142 M | 140 M | 157 M | 157 M | 157 M | 157 M | 142 M | 142 M | 142 M | 142 M | - | - | - | - | - | - | - | 26 K | 1.86 M | 1.86 M | 1.86 M | 1.86 M | 1.56 M | 1.56 M | 1.56 M | 1.56 M | 2.42 M | 2.42 M | 2.42 M | 2.42 M | 278 K | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
47.6 M | 62.2 M | 62 M | 62.6 M | 66.8 M | 64 M | 49.4 M | 38.8 M | 27.7 M | - | 36.9 M | 37.6 M | 37.6 M | 39.7 M | 51.6 M | 44.2 M | 44.2 M | 44.2 M | 44.2 M | 9.81 M | 9.81 M | 9.81 M | 9.81 M | 1.66 M | 1.66 M | 1.66 M | 1.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency